ROBOT-LONG-TERM
Regimen
- Experimental
- robot-assisted minimally invasive esophagectomy (RAMIE)
- Control
- open transthoracic esophagectomy (OTE)
Population
Resectable intrathoracic esophageal cancer (~80% received neoadjuvant CRT), 5-year follow-up
Key finding
5y OS 41% (RAMIE) vs 40% (OTE), P=0.83; 5y DFS 42% vs 43%, P=0.75. Oncologic equivalence at 5 years.
Source: PMID 33241302